Doxycycline for newly diagnosed type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether the antibiotic doxycycline can help control blood sugar in people newly diagnosed with type 2 diabetes. If you are over 40 and have not taken diabetes medications yet, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 40 years old.
- You have been newly diagnosed with type 2 diabetes.
- Your HbA1c (average blood sugar over 2-3 months) is above 6.5%.
- You do not have chronic kidney disease.
- You do not have liver disease.
- You do not have a mental or psychiatric condition.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding an SGLT2 inhibitor or a TZD medication to your current DPP4 inhibitor treatment can better manage your type 2 diabetes. It may be an option if your blood sugar levels are still too high.
This trial tests a combination of three diabetes medicines to see if they can quickly get high blood sugar under control in people newly diagnosed with type 2 diabetes. It's designed for those whose HbA1c is 9.0% or higher.
This trial is testing a combination of three diabetes medicines (henagliflozin, retagliptin, and metformin) in people newly diagnosed with type 2 diabetes. The goal is to see if this triple therapy works better for controlling blood sugar compared to standard treatments.
This study compares two different two-drug combinations for people recently diagnosed with type 2 diabetes. It aims to find which combination works better to control blood sugar and improve overall health.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This Phase 3 study tests whether LID104 can improve blood sugar control and safety in people with type 2 diabetes who are not meeting their A1c goal on metformin. You may benefit if your diabetes is still too high despite diet, exercise, and the usual metformin dose.
Hear when a new Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.